Related Experiment Video
Updated: Feb 7, 2026

Neurobehavioral Assessments in a Mouse Model of Neonatal Hypoxic-ischemic Brain Injury
Published on: November 24, 2017
The impact of hypoxic-ischemic brain injury on stem cell mobilization, migration, adhesion, and proliferation
Stephanie M Parry1, Eric S Peeples1
1Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA.
Insights
Therapeutic hypothermia is standard for neonatal hypoxic-ischemic encephalopathy (HIE). Stem cell therapy shows promise for HIE, with brain biomarkers potentially enhancing stem cell delivery to injured brain tissue.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Biomarker Discovery
Background:
- Neonatal hypoxic-ischemic encephalopathy (HIE) remains a leading cause of infant mortality and neurodevelopmental deficits.
- Current standard treatment, therapeutic hypothermia, offers limited efficacy for some infants.
- Stem cell transplantation is an emerging adjunctive therapy for improving HIE outcomes.
Purpose of the Study:
- To review brain-derived biomarkers released after hypoxic-ischemic injury.
- To examine the interaction between these biomarkers and stem cells.
- To elucidate how biomarker upregulation can optimize stem cell therapy for HIE.
Main Methods:
- Literature review of studies on neonatal HIE.
- Analysis of research on stem cell biology and neuroinflammation.
- Synthesis of data on biomarker-mediated stem cell recruitment.
Main Results:
- Hypoxic-ischemic injury triggers the release of specific chemical mediators from the brain.
- These mediators influence stem cell behavior, including migration and differentiation.
- Understanding these interactions is key to enhancing stem cell homing to the injured site.
Conclusions:
- Biomarkers released by the injured brain play a critical role in stem cell-mediated repair.
- Targeting and upregulating these biomarkers may significantly improve the efficacy of stem cell transplantation for HIE.
- Further research into biomarker-stem cell interactions can refine therapeutic strategies for neonatal brain injury.
Abstract:
Neonatal hypoxic-ischemic encephalopathy continues to be a significant cause of death or neurodevelopmental delays despite standard use of therapeutic hypothermia. The use of stem cell transplantation has recently emerged as a promising supplemental therapy to further improve the outcomes of infants with hypoxic-ischemic encephalopathy. After the injury, the brain releases several chemical mediators, many of which communicate directly with stem cells to encourage mobilization, migration, cell adhesion and differentiation. This manuscript reviews the biomarkers that are released from the injured brain and their interactions with stem cells, providing insight regarding how their upregulation could improve stem cell therapy by maximizing cell delivery to the injured tissue.
Related Concept Videos
Cell Migration
Cell Migration
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Embryonic Stem Cells
Cell Adhesion in Plants
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...
Cells Coordinate Growth and Proliferation

